Proof-of-concept study to assess impact of glycemic variability

June 25, 2015
Proof-of-concept study to assess impact of glycemic variability

(HealthDay)—A proof-of-concept study will be able to examine the contribution of glycemic variability to outcomes of type 2 diabetes, according to a report published online June 11 in Diabetes Care.

Jeffrey L. Probstfield, M.D., from the University of Washington in Seattle, and colleagues enrolled patients with insulin-requiring type 2 diabetes and high cardiovascular risk during a run-in period on basal bolus insulin (BBI). In an effort to maintain hemoglobin A1c (HbA1c) levels between 6.7 and 7.3 percent, 102 patients were randomly allocated to continue BBI or to with a prandial GLP-1 receptor agonist for six months. The primary outcome was glycemic variability, assessed by continuous glucose monitoring.

The researchers note that the mean age of the population was 62 years at randomization, with median diabetes duration of 16 years. Participants had a mean body mass index of 34 kg/m² and HbA1c of 7.9 percent. Of the patients, 32, 18, and 3 percent had a prior cardiovascular event, microalbuminuria, and macroalbuminuria, respectively. Between the groups, the continuous glucose monitoring coefficient of variation for was similar at baseline.

"We successfully randomized a population that has sufficient power to answer the primary question, address several secondary ones, and complete the protocol as designed," the authors write.

Several authors disclosed financial ties to pharmaceutical companies, including Sanofi, which is primarily funding the trial. Several have providing study funding and/or in-kind donations for the study.

Explore further: Low serum 25(OH)D3 in patients newly diagnosed with T2DM

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Low serum 25(OH)D3 in patients newly diagnosed with T2DM

June 15, 2015
(HealthDay)—Serum 25-hydroxyvitamin D3 (25[OH]D3) is associated with glucose-stimulated insulin secretion and β-cell function in individuals with newly diagnosed type 2 diabetes, according to a study published online June ...

Gender-based differences in glycemic control in T2DM

May 26, 2015
(HealthDay)—For patients with type 2 diabetes, there are gender-based differences in glycemic control and hypoglycemia after insulin treatment, according to research published in the June issue of Diabetes, Obesity and ...

Insulin LY2605541 tops glargine for glycemic control in T1DM

January 13, 2013
(HealthDay)—For patients with type 1 diabetes, the novel, long-acting basal insulin LY2605541 yields greater improvement in glycemic control compared with insulin glargine, according to a study published online Nov. 27 ...

Glycemic variability elevates risk of vascular events, death

May 16, 2014
(HealthDay)—Visit-to-visit variability (VVV) in glycated hemoglobin (HbA1c) and fasting glucose correlate with major adverse outcomes for patients with type 2 diabetes, according to a study published online May 8 in Diabetes ...

Intensive insulin rx lowers glycemic variability in early DM

April 15, 2014
(HealthDay)—Short-term intensive insulin therapy (IIT) can improve β-cell function in type 2 diabetes mellitus (T2DM) in association with decreased glycemic variability, according to a study published in the April issue ...

Islet transplantation safe, efficient in five-year follow-up

June 23, 2015
(HealthDay)—Islet transplantation seems safe and efficient for restoring glycemic control in type 1 diabetes, according to research published online June 11 in Diabetes Care.

Recommended for you

Deep brain stimulation found to improve diabetes symptoms

May 24, 2018
A team of researchers from several institutions in the Netherlands and Yale University in the U.S. has found evidence that suggests deep brain stimulation (DBS) can help treat type 2 diabetes. In their paper published in ...

Women with pregnancy-related diabetes may be at risk for chronic kidney disease

May 21, 2018
Gestational diabetes may predispose women to early-stage kidney damage, a precursor to chronic kidney disease, according to a study by researchers at the National Institutes of Health and other institutions. The study appears ...

Diabetes researchers find switch for fatty liver disease

May 17, 2018
Duke researchers have identified a key fork in the road for the way the liver deals with carbohydrates, fats and protein. They say it could be a promising new target for combating the pandemics of fatty liver disease and ...

New study of youth with type 1 diabetes connects 'honeymoon period' with lower LDL cholesterol

May 17, 2018
A new study by UMass Medical School physician-scientist Benjamin U. Nwosu, MD, finds that children with type 1 diabetes who experienced a partial clinical remission, or "honeymoon phase," had significantly lower low-density ...

"Living drug factories" may one day replace injections

May 17, 2018
Patients with diabetes generally rely on constant injections of insulin to control their disease. But MIT spinout Sigilon Therapeutics is developing an implantable, insulin-producing device that may one day make injections ...

Boosting the effects of vitamin D to tackle diabetes

May 10, 2018
More than 27 million people in the United States are living with type 2 diabetes, according to the Centers for Disease Control and Prevention. As the population ages and a growing percentage of people become overweight or ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.